Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats

Biochemical Pharmacology

Volumn 59, Issue 9, 2000, Pages 1155-1161

  Suntres, Zacharias E ^a   Shek, Pang N ^a  

^a DEF AND CIV INST OF ENVIRON MED   (Canada)

Author keywords

Acute lung injury; Dexamethasone; Inflammation; Lipopolysaccharide; Liposomes; Sepsis

Indexed keywords

ALKALINE PHOSPHATASE; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTASE; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOSOME; MYELOPEROXIDASE; PHOSPHOLIPASE A2; THROMBOXANE B2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHLORAMINES; DEXAMETHASONE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; LIPOSOMES; LUNG; MALE; ORGAN SIZE; PANCREATIC ELASTASE; PEPTIDYL-DIPEPTIDASE A; PEROXIDASE; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2;

EID: 0033969395     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00411-6     Document Type: Article

References (36)

1. Fink M.P., Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res. 49:1990;186-196.
2. Hewett J.A., Roth R.A. Hepatic and extrahepatic pathology of bacterial lipopolysaccharides. Pharmacol Rev. 45:1993;381-411.
3. Repine J.E. Scientific perspectives on adult respiratory distress syndrome. Lancet. 339:1992;466-472.
4. Glaucer M.P., Zanetti G., Baumgartner J.-D., Cohen J. Septic shock Pathogenesis . Lancet. 338:1991;732-739.
5. Fulkerson W.J., MacIntyre N., Stamler J., Crapo J.D. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med. 156:1996;29-38.
6. Rackow E.C., Astiz M.E. Mechanisms and management of septic shock. Circ Shock. 9:1993;219-237.
7. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-379.
8. Barnes P.J., Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis. 148:1993;S1-S26.
9. Check W.A., Kaliner M.A. Pharmacology and pharmacokinetics of topical corticosteroid derivatives used in asthma therapy. Am Rev Respir Dis. 141:1990;S44-S51.
10. Suntres Z.E., Shek P.N. Liposomes promote pulmonary glucocorticoid delivery. J Drug Target. 6:1998;175-182.
11. Taylor K.M.G., Farr S.J. Liposomes for drug delivery to the respiratory tract. Drug Dev Ind Pharm. 19:1993;123-142.
12. Suntres Z.E., Shek P.N. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing α-tocopherol and glutathione. Biochem Pharmacol. 52:1996;1515-1520.
13. 1-protease inhibitor reactive site. J Biol Chem. 254:1979;4027-4032.
14. 2. Biochem Biophys Res Commun. 167:1990;1309-1315.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
16. Witko-Sarsat V., Delacourt C., Rabier D., Bardet J., Nguyen A.T., Descamps-Latscha B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med. 152:1995;1910-1916.
17. Gad S.C., Weil C.S. Statistics for toxicologists. Hayes A.W. Principles and Methods of Toxicology. 1994;221-274 Raven Press, New York.
18. Lazo J.S., Lynch T.J., McCallister J. Bleomycin inhibition of angiotensin converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells. Am Rev Respir Dis. 134:1986;73-78.
19. Boudreau J., Nadeau D. Lung hydrolases in paraquat poisoning Early response of alkaline phosphatase . J Toxicol Environ Health. 22:1987;329-340.
20. Schraufstatter I.U., Cochrane C.G. Oxidants Types, sources, and mechanisms of injury . Crystal R.G., West J.B. Lung Injury. 1991;43-50 Raven Press, New York.
21. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation Estimation of neutrophil content with an enzyme marker . J Invest Dermatol. 78:1982;206-209.
22. Hubbard R.C., Brantly M.L., Crystal R.G. Proteases. Crystal R.G., West J.B. Lung Injury. 1991;3-13 Raven Press, New York.
23. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. J Biol Chem. 259:1984;10404-10413.
24. Barnes P.J. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med. 154:1996;S21-S27.
25. Williams K.M., Day R.O., Breit S.N. Biochemical actions and clinical pharmacology of anti-inflammatory drugs. Adv Drug Res. 24:1993;121-198.
26. Vane J., Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J. 1:1987;89-96.
27. Lopez-Garcia F., Vasquez-Auton J.M., Gil F., Latoore R., Moreno F., Villalain J., Gomez-Fernandez J.C. Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes. J Pharm Pharmacol. 45:1993;576-578.
28. de Silva M., Hazleman B.L. Page Thomas DP and Wraight P, Liposomes in arthritis A new approach . Lancet. 1:1979;1320-1322.
29. Williams T.J., Yarwood H. Effect of glucocorticoids on microvascular permeability. Am Rev Respir Dis. 141:1990;S39-S43.
30. Bone R.C. The pathogenesis of sepsis. Ann Intern Med. 115:1991;457-469.
31. Brigham K.L., Meyrick B. Endotoxin and the lung. Am Rev Respir Dis. 133:1986;913-927.
32. Sharar S.R., Winn R.K., Harlan J.M. Endotoxin-induced interactions of inflammatory cells within the lungs. Brigham K.L. Endotoxin and the Lungs. 1994;229-265 Marcel Dekker, New York.
33. Schreier H., Gonzalez-Rothi R.J., Stencenko A.A. Pulmonary delivery of liposomes. J Control Rel. 24:1993;209-223.
34. Taylor K.M.G., Newton J.M. Liposomes for controlled delivery of drugs to the lung. Thorax. 47:1992;257-259.
35. Henderson W. Eicosanoids and lung inflammation. Am Rev Respir Dis. 135:1987;1176-1185.
36. Stephenson A., Lonigoo J., Hyers T., Webster R.O., Fowler A.A. Increased concentration of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis. 138:1988;714-719.